Navin Pinto
Impact in
- Neurology top 1%
- Neuroblastoma Research and Treatments
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Papers in
- Co-authors
- Susan L. Cohn (16 shared papers)Julie R. Park (26 shared papers)Wendy B. London (8 shared papers)Mark A. Applebaum (8 shared papers)Samuel L. Volchenboum (6 shared papers)M. Eileen Dolan (1 shared paper)Andrew D.J. Pearson (2 shared papers)Gudrun Schleiermacher (2 shared papers)
- Journals
- Journal of Clinical Oncology (20 papers)Pediatric Blood & Cancer (11 papers)Neuro-Oncology (4 papers)Blood (3 papers)Clinical Cancer Research (2 papers)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Navin Pinto
58 papers receiving 2.0k citations
Navin Pinto's Hit Papers
Peers
Comparison fields: 5 of 86
- Neurology 968
- Cancer Research 382
- Oncology 563
- Genetics 114
- Molecular Biology 557
Countries citing papers authored by Navin Pinto
This map shows the geographic impact of Navin Pinto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Navin Pinto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Navin Pinto more than expected).
Fields of papers citing papers by Navin Pinto
This network shows the impact of papers produced by Navin Pinto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Navin Pinto. The network helps show where Navin Pinto may publish in the future.
Co-authors
The 25 scholars most cited alongside Navin Pinto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Advances in Risk Classification and Treatment Strategies for Neuroblastoma Hit paper breakdown → | 2015 | 621 |
| 2 | 2019 | 215 | |
| 3 | 2010 | 109 | |
| 4 | 2018 | 109 | |
| 5 | 2011 | 105 | |
| 6 | 2018 | 72 | |
| 7 | 2009 | 70 | |
| 8 | 2016 | 59 | |
| 9 | 2019 | 51 | |
| 10 | 2016 | 50 | |
| 11 | 2014 | 49 | |
| 12 | 2017 | 48 | |
| 13 | 2020 | 48 | |
| 14 | 2018 | 30 | |
| 15 | 2012 | 28 | |
| 16 | 2018 | 27 | |
| 17 | 2022 | 24 | |
| 18 | 2020 | 22 | |
| 19 | 2022 | 18 | |
| 20 | 2016 | 17 |
About Navin Pinto
Navin Pinto is a scholar working on Neurology, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 64 papers that have together received 2.0k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (27 papers), CAR-T cell therapy research (19 papers), Cancer Immunotherapy and Biomarkers (5 papers), Glioma Diagnosis and Treatment (5 papers), Sarcoma Diagnosis and Treatment (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Cancer Genomics and Diagnostics (3 papers) and Biosimilars and Bioanalytical Methods (3 papers). The work is most often cited by research in Neurology (968 citations), Cancer Research (382 citations), Oncology (563 citations), Genetics (114 citations) and Molecular Biology (557 citations). Navin Pinto has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Susan L. Cohn, Julie R. Park, Wendy B. London, Mark A. Applebaum, Samuel L. Volchenboum, M. Eileen Dolan, Andrew D.J. Pearson, Gudrun Schleiermacher, Katherine K. Matthay and Akira Nakagawara. Their work appears in journals such as Journal of Clinical Oncology, Pediatric Blood & Cancer, Neuro-Oncology, Blood and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.